LifeAire Systems, a technology leader in air purification for healthcare, has received CE mark certification for its line of in-duct air purification technologies, facilitating the introduction of the transformational technology into the European healthcare market.
LifeAire Systems’ proprietary technology for air purification provides continuous filtration and inactivation of 99.99% of biological and chemical contaminants within the air. Developed by Dr. Kathryn C. Worrilow, an IVF Laboratory Director and embryologist, who has spent more than a decade researching the critical role that air plays in in vitro fertilization, the technology provides the in vitro culture environment deemed optimal for successful embryogenesis. The LifeAire Systems’ filtration method is in stark contrast to more common HEPA filtration systems that filter air but do not provide molecular destruction of biological and chemical contaminants. The LifeAire Systems’ purification process offers a continuous, dynamic kill and removal of airborne chemical and biological pathogens.
Since its introduction into the market in 2014, the LifeAire technology has been instrumental in helping IVF clinics achieve industry-leading performance metrics in high pregnancy rates and reduced loss rates, often up to 20% above industry averages.
We at LifeAire are excited to announce that we have met all required European Union (EU) regulatory manufacturing standards in order to achieve CE certification, which will allow us to share our revolutionary technology with our European colleagues and into one of the world’s largest economic markets.